DK1079834T3 - Stabile sammensætninger omfattende levosimendan og alginsyre - Google Patents

Stabile sammensætninger omfattende levosimendan og alginsyre

Info

Publication number
DK1079834T3
DK1079834T3 DK99916943T DK99916943T DK1079834T3 DK 1079834 T3 DK1079834 T3 DK 1079834T3 DK 99916943 T DK99916943 T DK 99916943T DK 99916943 T DK99916943 T DK 99916943T DK 1079834 T3 DK1079834 T3 DK 1079834T3
Authority
DK
Denmark
Prior art keywords
levosimendan
alginic acid
stable compositions
compositions
stable
Prior art date
Application number
DK99916943T
Other languages
Danish (da)
English (en)
Inventor
Maarit Baeckmann
Ilkka Larma
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of DK1079834T3 publication Critical patent/DK1079834T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK99916943T 1998-04-23 1999-04-23 Stabile sammensætninger omfattende levosimendan og alginsyre DK1079834T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia
PCT/FI1999/000331 WO1999055337A1 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid

Publications (1)

Publication Number Publication Date
DK1079834T3 true DK1079834T3 (da) 2003-04-07

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916943T DK1079834T3 (da) 1998-04-23 1999-04-23 Stabile sammensætninger omfattende levosimendan og alginsyre

Country Status (33)

Country Link
US (1) US6531458B1 (zh)
EP (1) EP1079834B1 (zh)
JP (1) JP4475809B2 (zh)
KR (1) KR100590622B1 (zh)
CN (1) CN1165309C (zh)
AT (1) ATE231395T1 (zh)
AU (1) AU756338B2 (zh)
BG (1) BG64766B1 (zh)
BR (1) BR9909867A (zh)
CA (1) CA2329232C (zh)
CZ (1) CZ290911B6 (zh)
DE (1) DE69905034T2 (zh)
DK (1) DK1079834T3 (zh)
EA (1) EA002428B1 (zh)
EE (1) EE04143B1 (zh)
ES (1) ES2191426T3 (zh)
FI (1) FI980902A (zh)
GE (1) GEP20032942B (zh)
HK (1) HK1031998A1 (zh)
HR (1) HRP20000703B1 (zh)
HU (1) HUP0105446A3 (zh)
ID (1) ID26650A (zh)
IL (2) IL138950A0 (zh)
MX (1) MXPA00010368A (zh)
NO (1) NO318575B1 (zh)
NZ (1) NZ507455A (zh)
PL (1) PL192274B1 (zh)
PT (1) PT1079834E (zh)
RS (1) RS49955B (zh)
SK (1) SK284600B6 (zh)
TR (1) TR200003101T2 (zh)
WO (1) WO1999055337A1 (zh)
ZA (1) ZA200005630B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
JPWO2002064120A1 (ja) * 2001-02-13 2004-06-10 大正製薬株式会社 内服ゲル製剤
US20080194567A1 (en) * 2005-03-14 2008-08-14 Piero Pollesello Combination Treatment for Enhancing Diuresis
PL3370693T3 (pl) * 2015-11-06 2020-07-13 Carinopharm Gmbh Ulepszone preparaty lewosimendanu do podawania dożylnego w postaci roztworów do wlewów lub wstrzykiwań i koncentratu do wlewów
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NZ203684A (en) * 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
CN1165309C (zh) 2004-09-08
RS49955B (sr) 2008-09-29
ATE231395T1 (de) 2003-02-15
HUP0105446A2 (hu) 2002-07-29
FI980902A (fi) 1999-10-24
WO1999055337A1 (en) 1999-11-04
SK284600B6 (sk) 2005-07-01
NO20005312L (no) 2000-11-21
EP1079834A1 (en) 2001-03-07
KR20010072577A (ko) 2001-07-31
BG64766B1 (bg) 2006-03-31
FI980902A0 (fi) 1998-04-23
TR200003101T2 (tr) 2001-01-22
HUP0105446A3 (en) 2002-09-30
JP4475809B2 (ja) 2010-06-09
EA002428B1 (ru) 2002-04-25
DE69905034D1 (de) 2003-02-27
IL138950A (en) 2006-08-20
AU756338B2 (en) 2003-01-09
HK1031998A1 (en) 2001-07-06
BR9909867A (pt) 2000-12-19
HRP20000703A2 (en) 2001-04-30
CZ290911B6 (cs) 2002-11-13
NZ507455A (en) 2002-02-01
PL192274B1 (pl) 2006-09-29
YU64000A (sh) 2002-12-10
HRP20000703B1 (en) 2009-11-30
MXPA00010368A (es) 2002-07-02
CZ20003779A3 (en) 2001-05-16
CA2329232A1 (en) 1999-11-04
CN1298303A (zh) 2001-06-06
EP1079834B1 (en) 2003-01-22
EA200001097A1 (ru) 2001-04-23
DE69905034T2 (de) 2003-09-04
PT1079834E (pt) 2003-04-30
NO20005312D0 (no) 2000-10-20
EE200000616A (et) 2002-06-17
BG104958A (en) 2001-07-31
ES2191426T3 (es) 2003-09-01
GEP20032942B (en) 2003-04-25
JP2002512964A (ja) 2002-05-08
US6531458B1 (en) 2003-03-11
SK15552000A3 (sk) 2001-05-10
NO318575B1 (no) 2005-04-11
IL138950A0 (en) 2001-11-25
PL343722A1 (en) 2001-09-10
CA2329232C (en) 2007-10-30
ZA200005630B (en) 2002-01-14
AU3524899A (en) 1999-11-16
ID26650A (id) 2001-01-25
KR100590622B1 (ko) 2006-06-19
EE04143B1 (et) 2003-10-15

Similar Documents

Publication Publication Date Title
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
TR200103216T2 (tr) Pirimidinon bileşimleri
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
NO992617D0 (no) Sulfinsyrederivater, deres fremstilling og anvendelse
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
DE60143906D1 (de) Verwendung von derivaten der 2-oxothiazolidin-4-corbonsäure als prä-abschuppungsmittel
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
ATE213937T1 (de) Spezielle halofantrinhaltige zusammensetzungen
DK1079834T3 (da) Stabile sammensætninger omfattende levosimendan og alginsyre
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
NO20003758L (no) Trekonserveringsmidler
DK0921806T3 (da) Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
TR200200278T2 (tr) Kalsilitik bileşimler
ATE522601T1 (de) Varianten von antithrombin iii
DE60029624D1 (de) Homologe enzyme der humanen heparanase sowie alternative spleissformen davon
ATE361757T1 (de) Stabile fumagillin-formulierung
ATE302023T1 (de) Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
DE60137506D1 (de) Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose
ATE184155T1 (de) Verwendung der jodwasserstoffsäure als aphrodisiakum
ATE290874T1 (de) Verwendung von niedermolekularen heparin zur behandlung von osteoarthrose
DE50003481D1 (de) Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen
UA30826A (uk) Спосіб лікування хейліту
DE60218726D1 (de) Verwendung von 4-oxo-butansäure derivaten zur behandlung der entzündung
UA32651C2 (uk) Спосіб напіввідкритої лапаростомії
UA10455A (uk) Склад для обробки пласта